ASX - By Stock
|
ADR |
Re:
Ann: US FDA clearance of Hailie for AstraZeneca inhalers
|
|
Hercepin
|
75 |
18K |
1 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
75
|
18K
|
1
|
|
ASX - By Stock
|
LEL |
Re:
Ann: Merger & IPO Spin-Out of LEL and NVX Natural Graphite Assets
|
|
Hercepin
|
130 |
29K |
6 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
130
|
29K
|
6
|
|
ASX - By Stock
|
CDX |
Re:
Ann: CDX January 2024 Webinar Presentation
|
|
Hercepin
|
9 |
4.0K |
11 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
9
|
4.0K
|
11
|
|
ASX - By Stock
|
LEL |
Re:
Ann: Battery Grade Lithium Carbonate Successfully Produced
|
|
Hercepin
|
59 |
11K |
0 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
59
|
11K
|
0
|
|
ASX - By Stock
|
PLL |
Re:
PLL General Discussion
|
|
Hercepin
|
2.3K |
785K |
6 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
2.3K
|
785K
|
6
|
|
ASX - By Stock
|
CDX |
Re:
Ann: CardieX AGM Executive Update
|
|
Hercepin
|
39 |
12K |
8 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
39
|
12K
|
8
|
|
ASX - By Stock
|
CY5 |
Re:
Ann: Spectacular rock chip results up to 6.6% Li2O from Pegasus
|
|
Hercepin
|
29 |
8.9K |
5 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
29
|
8.9K
|
5
|
|
ASX - By Stock
|
LEL |
Re:
LEL - The Sleeping Giant
|
|
Hercepin
|
1.1K |
259K |
0 |
17/10/23 |
17/10/23 |
ASX - By Stock
|
1.1K
|
259K
|
0
|
|
ASX - By Stock
|
CDX |
Re:
Ann: CardieX Files Form F-1 to Dual List on US Nasdaq Exchange
|
|
Hercepin
|
48 |
12K |
10 |
26/07/23 |
26/07/23 |
ASX - By Stock
|
48
|
12K
|
10
|
|
ASX - By Stock
|
LEL |
Re:
LEL - The Sleeping Giant
|
|
Hercepin
|
1.1K |
259K |
1 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
1.1K
|
259K
|
1
|
|
ASX - By Stock
|
CDX Biotech |
Re:
General Forum
|
|
Hercepin
|
1.7K |
569K |
7 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
1.7K
|
569K
|
7
|
|
ASX - By Stock
|
LEL |
Re:
Ann: Assays Confirm Lithium in Massive Intersections at Solaroz
|
|
Hercepin
|
138 |
28K |
3 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
138
|
28K
|
3
|
|
ASX - By Stock
|
VTM |
Re:
Ann: RC DRILLING ASSAYS COMPLETED WITH HIGH CONTENT OF HEAVY REE
|
|
Hercepin
|
52 |
12K |
6 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
52
|
12K
|
6
|
|
ASX - By Stock
|
VTM |
Re:
Ann: RC DRILLING ASSAYS COMPLETED WITH HIGH CONTENT OF HEAVY REE
|
|
Hercepin
|
52 |
12K |
4 |
15/05/23 |
15/05/23 |
ASX - By Stock
|
52
|
12K
|
4
|
|
ASX - By Stock
|
CDX |
Re:
Ann: Trading Halt
|
|
Hercepin
|
146 |
36K |
12 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
146
|
36K
|
12
|
|
ASX - By Stock
|
CDX |
Re:
Ann: Trading Halt
|
|
Hercepin
|
146 |
36K |
8 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
146
|
36K
|
8
|
|
ASX - By Stock
|
OM1 |
Re:
Ann: Corporate Presentation - Lac des Montagnes Lithium Project
|
|
Hercepin
|
32 |
10K |
6 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
32
|
10K
|
6
|
|
ASX - By Stock
|
CDX |
Re:
Ann: Trading Halt
|
|
Hercepin
|
146 |
36K |
6 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
146
|
36K
|
6
|
|
ASX - By Stock
|
CDX |
Re:
Ann: Trading Halt
|
|
Hercepin
|
146 |
36K |
5 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
146
|
36K
|
5
|
|
ASX - By Stock
|
CDX Biotech |
Re:
General Forum
|
|
Hercepin
|
1.7K |
569K |
3 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
1.7K
|
569K
|
3
|
|
ASX - By Stock
|
LEL |
Re:
Ann: Significant High Grade Graphite Intercepts Continue at Burke
|
|
Hercepin
|
59 |
17K |
3 |
30/03/23 |
30/03/23 |
ASX - By Stock
|
59
|
17K
|
3
|
|
ASX - By Stock
|
LEL |
Re:
Ann: Presentation at Paydirt's 2023 Battery Minerals Conference
|
|
Hercepin
|
47 |
11K |
4 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
47
|
11K
|
4
|
|
ASX - By Stock
|
LEL |
Re:
Ann: Burke Graphite Metallurgical Testwork Commences in China
|
|
Hercepin
|
32 |
6.0K |
4 |
16/03/23 |
16/03/23 |
ASX - By Stock
|
32
|
6.0K
|
4
|
|
ASX - By Stock
|
CDX Biotech |
Re:
General Forum
|
|
Hercepin
|
1.7K |
569K |
12 |
02/03/23 |
02/03/23 |
ASX - By Stock
|
1.7K
|
569K
|
12
|
|
ASX - By Stock
|
CY5 |
Re:
Ann: First High-Grade Assay Results from Pontax
|
|
Hercepin
|
46 |
15K |
10 |
14/02/23 |
14/02/23 |
ASX - By Stock
|
46
|
15K
|
10
|
|
ASX - By Stock
|
VTM |
Re:
Ann: 1.08% High Grade TREO Assay from recent RC Drilling
|
|
Hercepin
|
40 |
10K |
5 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
40
|
10K
|
5
|
|
ASX - By Stock
|
LEL |
Re:
Ann: Burke Continues to Deliver Exceptional Drilling Results
|
|
Hercepin
|
59 |
13K |
2 |
09/02/23 |
09/02/23 |
ASX - By Stock
|
59
|
13K
|
2
|
|
ASX - By Stock
|
CDX |
Re:
Ann: Trading Halt
|
|
Hercepin
|
20 |
5.6K |
22 |
07/02/23 |
07/02/23 |
ASX - By Stock
|
20
|
5.6K
|
22
|
|
ASX - By Stock
|
CDX Biotech |
Re:
General Forum
|
|
Hercepin
|
1.7K |
569K |
23 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
1.7K
|
569K
|
23
|
|
ASX - By Stock
|
CDX Biotech |
Re:
General Forum
|
|
Hercepin
|
1.7K |
569K |
9 |
23/01/23 |
23/01/23 |
ASX - By Stock
|
1.7K
|
569K
|
9
|
|
ASX - By Stock
|
CUF |
Re:
CUF - A Bright Future For Shareholders
|
|
Hercepin
|
444 |
166K |
3 |
20/01/23 |
20/01/23 |
ASX - By Stock
|
444
|
166K
|
3
|
|
ASX - By Stock
|
CDX |
Re:
CONNEQTHEALTH goes live
|
|
Hercepin
|
77 |
21K |
19 |
06/01/23 |
06/01/23 |
ASX - By Stock
|
77
|
21K
|
19
|
|
ASX - By Stock
|
RAS |
Re:
Ann: NT Lithium Project Update - Drilling Results
|
|
Hercepin
|
51 |
21K |
14 |
13/12/22 |
13/12/22 |
ASX - By Stock
|
51
|
21K
|
14
|
|
ASX - By Stock
|
LEL |
Re:
Ann: Drilling Programme Advances at Solaroz Lithium Brine Project
|
|
Hercepin
|
23 |
6.2K |
1 |
12/12/22 |
12/12/22 |
ASX - By Stock
|
23
|
6.2K
|
1
|
|
ASX - By Stock
|
GMN |
Re:
Are we the next LRS?
|
|
Hercepin
|
102 |
29K |
3 |
12/12/22 |
12/12/22 |
ASX - By Stock
|
102
|
29K
|
3
|
|
ASX - By Stock
|
CDX |
Re:
Ann: CardieX Announces Significant New Clinical Trial Agreement
|
|
Hercepin
|
63 |
18K |
19 |
12/12/22 |
12/12/22 |
ASX - By Stock
|
63
|
18K
|
19
|
|
ASX - By Stock
|
CDX |
Re:
Ann: CardieX Announces Significant New Clinical Trial Agreement
|
|
Hercepin
|
63 |
18K |
8 |
09/12/22 |
09/12/22 |
ASX - By Stock
|
63
|
18K
|
8
|
|
ASX - By Stock
|
CDX Biotech |
Re:
General Forum
|
|
Hercepin
|
1.7K |
569K |
13 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
1.7K
|
569K
|
13
|
|
ASX - By Stock
|
GMN |
Re:
Ann: Gold Mountain Exercises Option over 20% of Brazil Lithium JV
|
|
Hercepin
|
84 |
19K |
1 |
21/11/22 |
21/11/22 |
ASX - By Stock
|
84
|
19K
|
1
|
|
ASX - By Stock
|
ENR |
Re:
Ann: ********* Investor Presentation
|
|
Hercepin
|
2 |
1.6K |
7 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
2
|
1.6K
|
7
|
|
ASX - By Stock
|
CDX |
Re:
Ann: CardieX Acquires Core Assets from Blumio, Inc
|
|
Hercepin
|
17 |
5.2K |
10 |
16/11/22 |
16/11/22 |
ASX - By Stock
|
17
|
5.2K
|
10
|
|
ASX - By Stock
|
CY5 |
Re:
Ann: Maiden Resource Drilling Commenced
|
|
Hercepin
|
89 |
25K |
3 |
16/11/22 |
16/11/22 |
ASX - By Stock
|
89
|
25K
|
3
|
|
ASX - By Stock
|
CDX |
Re:
Cardiex acquires Blumio
|
|
Hercepin
|
32 |
9.6K |
5 |
16/11/22 |
16/11/22 |
ASX - By Stock
|
32
|
9.6K
|
5
|
|
ASX - By Stock
|
ENR |
Re:
Ann: EIS Co-Funding for West Arunta Cu-REE Drill Program
|
|
Hercepin
|
21 |
8.4K |
6 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
21
|
8.4K
|
6
|
|
ASX - By Stock
|
CDX Biotech |
Re:
General Forum
|
|
Hercepin
|
1.7K |
569K |
11 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
1.7K
|
569K
|
11
|
|
ASX - By Stock
|
GMN |
Re:
OPTIONS - GMNOA & GMNOB
|
|
Hercepin
|
61 |
14K |
3 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
61
|
14K
|
3
|
|
ASX - By Stock
|
NFL |
Re:
Ann: Native Copper intersected in First Hole
|
|
Hercepin
|
178 |
63K |
8 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
178
|
63K
|
8
|
|
ASX - By Stock
|
OD6 |
Re:
Ann: ANU Rare Earth Conference - Technical Presentation
|
|
Hercepin
|
71 |
15K |
4 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
71
|
15K
|
4
|
|
ASX - By Stock
|
CDX |
Re:
Ann: CDX Announces SPP Launch, Booklet & Timetable
|
|
Hercepin
|
17 |
6.2K |
6 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
17
|
6.2K
|
6
|
|
ASX - By Stock
|
CDX |
Re:
Ann: CardieX Submits FDA Application for CONNEQT Pulse
|
|
Hercepin
|
110 |
35K |
5 |
14/09/22 |
14/09/22 |
ASX - By Stock
|
110
|
35K
|
5
|
|